SEED Therapeutics announced that the U.S. Food and Drug Administration has granted Rare Pediatric Disease and Orphan Drug designations to ...

An investigational higher dose of spinal muscular atrophy drug nusinersen gains attention as the FDA and European Medicines ...

The revision of labeling for products approved or submitted for approval under an abbreviated new drug application (ANDA) depends on the labeling of the listed drug referenced in the ANDA.

The US Food and Drug Administration (FDA) has approved the abbreviated new drug application (ANDA) of Lupin’s Sacubitril and ...

Scientists have unveiled a groundbreaking method to test how thousands of active substances influence cellular metabolism ...

Discover the potential of macrocycles in drug discovery: flexible, cell-permeable molecules targeting undruggable proteins.

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

Recent research has focused on harnessing these properties for various biomedical applications, including targeted drug delivery systems ... biosilica has opened new avenues in plasmonics ...

Objectives Characterise US residents’ exposure to restrictions on sales of flavoured electronic nicotine delivery system ...

To be clear, there will always be challenges in drug ... application of them, a more systematic approach to ECAs must be embedded into the overall development process. This can require new ...